Copyright Reports & Markets. All rights reserved.

Global RNA-Targeted Small Molecules Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global RNA-Targeted Small Molecules Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 mRNA Translation Regulation
    • 1.2.3 RNA Splicing Modification
    • 1.2.4 Direct RNA Targeting
    • 1.2.5 Indirect RNA Targeting - Epitranscriptomics
  • 1.3 Market by Application
    • 1.3.1 Global RNA-Targeted Small Molecules Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals
    • 1.3.3 Laboratories
    • 1.3.4 Phamacy
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global RNA-Targeted Small Molecules Market Perspective (2016-2027)
  • 2.2 RNA-Targeted Small Molecules Growth Trends by Regions
    • 2.2.1 RNA-Targeted Small Molecules Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 RNA-Targeted Small Molecules Historic Market Share by Regions (2016-2021)
    • 2.2.3 RNA-Targeted Small Molecules Forecasted Market Size by Regions (2022-2027)
  • 2.3 RNA-Targeted Small Molecules Industry Dynamic
    • 2.3.1 RNA-Targeted Small Molecules Market Trends
    • 2.3.2 RNA-Targeted Small Molecules Market Drivers
    • 2.3.3 RNA-Targeted Small Molecules Market Challenges
    • 2.3.4 RNA-Targeted Small Molecules Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top RNA-Targeted Small Molecules Players by Revenue
    • 3.1.1 Global Top RNA-Targeted Small Molecules Players by Revenue (2016-2021)
    • 3.1.2 Global RNA-Targeted Small Molecules Revenue Market Share by Players (2016-2021)
  • 3.2 Global RNA-Targeted Small Molecules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by RNA-Targeted Small Molecules Revenue
  • 3.4 Global RNA-Targeted Small Molecules Market Concentration Ratio
    • 3.4.1 Global RNA-Targeted Small Molecules Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by RNA-Targeted Small Molecules Revenue in 2020
  • 3.5 RNA-Targeted Small Molecules Key Players Head office and Area Served
  • 3.6 Key Players RNA-Targeted Small Molecules Product Solution and Service
  • 3.7 Date of Enter into RNA-Targeted Small Molecules Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 RNA-Targeted Small Molecules Breakdown Data by Type

  • 4.1 Global RNA-Targeted Small Molecules Historic Market Size by Type (2016-2021)
  • 4.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Type (2022-2027)

5 RNA-Targeted Small Molecules Breakdown Data by Application

  • 5.1 Global RNA-Targeted Small Molecules Historic Market Size by Application (2016-2021)
  • 5.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America RNA-Targeted Small Molecules Market Size (2016-2027)
  • 6.2 North America RNA-Targeted Small Molecules Market Size by Type
    • 6.2.1 North America RNA-Targeted Small Molecules Market Size by Type (2016-2021)
    • 6.2.2 North America RNA-Targeted Small Molecules Market Size by Type (2022-2027)
    • 6.2.3 North America RNA-Targeted Small Molecules Market Size by Type (2016-2027)
  • 6.3 North America RNA-Targeted Small Molecules Market Size by Application
    • 6.3.1 North America RNA-Targeted Small Molecules Market Size by Application (2016-2021)
    • 6.3.2 North America RNA-Targeted Small Molecules Market Size by Application (2022-2027)
    • 6.3.3 North America RNA-Targeted Small Molecules Market Size by Application (2016-2027)
  • 6.4 North America RNA-Targeted Small Molecules Market Size by Country
    • 6.4.1 North America RNA-Targeted Small Molecules Market Size by Country (2016-2021)
    • 6.4.2 North America RNA-Targeted Small Molecules Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe RNA-Targeted Small Molecules Market Size (2016-2027)
  • 7.2 Europe RNA-Targeted Small Molecules Market Size by Type
    • 7.2.1 Europe RNA-Targeted Small Molecules Market Size by Type (2016-2021)
    • 7.2.2 Europe RNA-Targeted Small Molecules Market Size by Type (2022-2027)
    • 7.2.3 Europe RNA-Targeted Small Molecules Market Size by Type (2016-2027)
  • 7.3 Europe RNA-Targeted Small Molecules Market Size by Application
    • 7.3.1 Europe RNA-Targeted Small Molecules Market Size by Application (2016-2021)
    • 7.3.2 Europe RNA-Targeted Small Molecules Market Size by Application (2022-2027)
    • 7.3.3 Europe RNA-Targeted Small Molecules Market Size by Application (2016-2027)
  • 7.4 Europe RNA-Targeted Small Molecules Market Size by Country
    • 7.4.1 Europe RNA-Targeted Small Molecules Market Size by Country (2016-2021)
    • 7.4.2 Europe RNA-Targeted Small Molecules Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific RNA-Targeted Small Molecules Market Size (2016-2027)
  • 8.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type
    • 8.2.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application
    • 8.3.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region
    • 8.4.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America RNA-Targeted Small Molecules Market Size (2016-2027)
  • 9.2 Latin America RNA-Targeted Small Molecules Market Size by Type
    • 9.2.1 Latin America RNA-Targeted Small Molecules Market Size by Type (2016-2021)
    • 9.2.2 Latin America RNA-Targeted Small Molecules Market Size by Type (2022-2027)
    • 9.2.3 Latin America RNA-Targeted Small Molecules Market Size by Type (2016-2027)
  • 9.3 Latin America RNA-Targeted Small Molecules Market Size by Application
    • 9.3.1 Latin America RNA-Targeted Small Molecules Market Size by Application (2016-2021)
    • 9.3.2 Latin America RNA-Targeted Small Molecules Market Size by Application (2022-2027)
    • 9.3.3 Latin America RNA-Targeted Small Molecules Market Size by Application (2016-2027)
  • 9.4 Latin America RNA-Targeted Small Molecules Market Size by Country
    • 9.4.1 Latin America RNA-Targeted Small Molecules Market Size by Country (2016-2021)
    • 9.4.2 Latin America RNA-Targeted Small Molecules Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa RNA-Targeted Small Molecules Market Size (2016-2027)
  • 10.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type
    • 10.2.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application
    • 10.3.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country
    • 10.4.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Accent Therapeutics
    • 11.1.1 Accent Therapeutics Company Details
    • 11.1.2 Accent Therapeutics Business Overview
    • 11.1.3 Accent Therapeutics RNA-Targeted Small Molecules Introduction
    • 11.1.4 Accent Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
    • 11.1.5 Accent Therapeutics Recent Development
  • 11.2 Anima Biotech Inc.
    • 11.2.1 Anima Biotech Inc. Company Details
    • 11.2.2 Anima Biotech Inc. Business Overview
    • 11.2.3 Anima Biotech Inc. RNA-Targeted Small Molecules Introduction
    • 11.2.4 Anima Biotech Inc. Revenue in RNA-Targeted Small Molecules Business (2016-2021)
    • 11.2.5 Anima Biotech Inc. Recent Development
  • 11.3 Arrakis Pharmaceuticals
    • 11.3.1 Arrakis Pharmaceuticals Company Details
    • 11.3.2 Arrakis Pharmaceuticals Business Overview
    • 11.3.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Introduction
    • 11.3.4 Arrakis Pharmaceuticals Revenue in RNA-Targeted Small Molecules Business (2016-2021)
    • 11.3.5 Arrakis Pharmaceuticals Recent Development
  • 11.4 Epics Therapeutics
    • 11.4.1 Epics Therapeutics Company Details
    • 11.4.2 Epics Therapeutics Business Overview
    • 11.4.3 Epics Therapeutics RNA-Targeted Small Molecules Introduction
    • 11.4.4 Epics Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
    • 11.4.5 Epics Therapeutics Recent Development
  • 11.5 Expansion Therapeutics
    • 11.5.1 Expansion Therapeutics Company Details
    • 11.5.2 Expansion Therapeutics Business Overview
    • 11.5.3 Expansion Therapeutics RNA-Targeted Small Molecules Introduction
    • 11.5.4 Expansion Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
    • 11.5.5 Expansion Therapeutics Recent Development
  • 11.6 Gotham Therapeutics
    • 11.6.1 Gotham Therapeutics Company Details
    • 11.6.2 Gotham Therapeutics Business Overview
    • 11.6.3 Gotham Therapeutics RNA-Targeted Small Molecules Introduction
    • 11.6.4 Gotham Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
    • 11.6.5 Gotham Therapeutics Recent Development
  • 11.7 H3 Biomedicine
    • 11.7.1 H3 Biomedicine Company Details
    • 11.7.2 H3 Biomedicine Business Overview
    • 11.7.3 H3 Biomedicine RNA-Targeted Small Molecules Introduction
    • 11.7.4 H3 Biomedicine Revenue in RNA-Targeted Small Molecules Business (2016-2021)
    • 11.7.5 H3 Biomedicine Recent Development
  • 11.8 Ribometrix
    • 11.8.1 Ribometrix Company Details
    • 11.8.2 Ribometrix Business Overview
    • 11.8.3 Ribometrix RNA-Targeted Small Molecules Introduction
    • 11.8.4 Ribometrix Revenue in RNA-Targeted Small Molecules Business (2016-2021)
    • 11.8.5 Ribometrix Recent Development
  • 11.9 Skyhawk Therapeutics
    • 11.9.1 Skyhawk Therapeutics Company Details
    • 11.9.2 Skyhawk Therapeutics Business Overview
    • 11.9.3 Skyhawk Therapeutics RNA-Targeted Small Molecules Introduction
    • 11.9.4 Skyhawk Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
    • 11.9.5 Skyhawk Therapeutics Recent Development
  • 11.10 STORM Therapeutics
    • 11.10.1 STORM Therapeutics Company Details
    • 11.10.2 STORM Therapeutics Business Overview
    • 11.10.3 STORM Therapeutics RNA-Targeted Small Molecules Introduction
    • 11.10.4 STORM Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
    • 11.10.5 STORM Therapeutics Recent Development
  • 11.11 Twentyeight-Seven Therapeutics
    • 11.11.1 Twentyeight-Seven Therapeutics Company Details
    • 11.11.2 Twentyeight-Seven Therapeutics Business Overview
    • 11.11.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Introduction
    • 11.11.4 Twentyeight-Seven Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
    • 11.11.5 Twentyeight-Seven Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global RNA-Targeted Small Molecules Scope and Market Size
    RNA-Targeted Small Molecules market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global RNA-Targeted Small Molecules market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    mRNA Translation Regulation
    RNA Splicing Modification
    Direct RNA Targeting
    Indirect RNA Targeting - Epitranscriptomics

    Segment by Application
    Hospitals
    Laboratories
    Phamacy

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Accent Therapeutics
    Anima Biotech Inc.
    Arrakis Pharmaceuticals
    Epics Therapeutics
    Expansion Therapeutics
    Gotham Therapeutics
    H3 Biomedicine
    Ribometrix
    Skyhawk Therapeutics
    STORM Therapeutics
    Twentyeight-Seven Therapeutics

    Buy now